Literature DB >> 31647312

Weighted Gene Coexpression Network Analysis Reveals the Critical lncRNAs and mRNAs in Development of Hirschsprung's Disease.

Xiaoguang Niu1,2, Yongtao Xu2, Ni Gao1, Aiwu Li1.   

Abstract

Hirschsprung's disease (HSCR) is a common newborn defect. This study aimed to identify critical genes involved in the development of HSCR. Differently expressed genes (DEGs) of public data set GSE98502 were analyzed using paired t-test. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed using Database for Annotation, Visualization and Integrated Discovery (DAVID) 6.8. Besides, Coexpression network of long noncoding RNAs (lncRNAs)-mRNAs (message RNA) were constructed using weighted gene coexpression network analysis. The key modules were filtered out by calculating the module-trait correlations. Then, hub genes were screened and the expression of these genes was further validated in an independent data set GSE96854. We identified 864 DEGs enriched in 19 GO biological functions such as negative regulation of growth and regulation of heart contraction; 11 KEGG pathways such as mineral absorption and protein digestion and absorption. lncRNAs-mRNAs coexpressed network was constructed, including 8 modules and 177 genes. Hub lncRNAs, including LINC00619, LINC00924, LINC00261, and DRAIC, were identified. Hub mRNAs, including CYCS, CCND1, BDKRB, ITGA6, and TNNC1, were mainly enriched in cancer pathways, p53 signaling pathway, and calcium signaling pathway. The expressions of the hub mRNAs were successfully validated by another independent GSE96854 data set. Our findings indicated the hub lncRNAs, including LINC00619, LINC00924, LINC00261, and DRAIC, as well as hub mRNAs, including CYCS, CCND1, BDKRB, ITGA6, and TNNC1, might involve in the progression of HSCR, and these genes might provide new clinical biomarkers for risk evaluation of HSCR.

Entities:  

Keywords:  Hirschsprung's disease; clinical biomarker; weight gene coexpression network analysis

Year:  2019        PMID: 31647312     DOI: 10.1089/cmb.2019.0261

Source DB:  PubMed          Journal:  J Comput Biol        ISSN: 1066-5277            Impact factor:   1.479


  4 in total

1.  LncRNA DRAIC inhibits proliferation and metastasis of gastric cancer cells through interfering with NFRKB deubiquitination mediated by UCHL5.

Authors:  Zheng Zhang; Xiaoxuan Hu; Jia Kuang; Jinmao Liao; Qi Yuan
Journal:  Cell Mol Biol Lett       Date:  2020-04-25       Impact factor: 5.787

2.  LncRNA DRAIC regulates cell proliferation and migration by affecting the miR-34a-5p/ITGA6 signal axis in Hirschsprung's disease.

Authors:  Chuancheng Sun; Bing Xu; Liang Wang; Yilin Su
Journal:  Ups J Med Sci       Date:  2021-08-20       Impact factor: 2.384

Review 3.  The emerging potentials of lncRNA DRAIC in human cancers.

Authors:  Qinfan Yao; Xiuyuan Zhang; Dajin Chen
Journal:  Front Oncol       Date:  2022-08-04       Impact factor: 5.738

4.  Identification of New Potential LncRNA Biomarkers in Hirschsprung Disease.

Authors:  Ana Torroglosa; Leticia Villalba-Benito; Raquel María Fernández; Berta Luzón-Toro; María José Moya-Jiménez; Guillermo Antiñolo; Salud Borrego
Journal:  Int J Mol Sci       Date:  2020-08-02       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.